Blood Vessel Leakage: Pathophysiology, Consequences & Prevention

Vascular Leakage = Loss of Endothelial Barrier Integrity

The endothelium regulates permeability via junctional proteins (VE-cadherin, claudins, occludin), glycocalyx, and cytoskeletal tone. Disruption → plasma extravasation.

Consequences by Severity & Location

Manifestation	Mechanism	Clinical Example
Hemorrhage	Structural breach (trauma, aneurysm rupture, vasculitis)	Hemothorax, retroperitoneal bleed, GI bleed
Edema	Increased hydraulic permeability (inflammatory mediators: histamine, VEGF, bradykinin)	Pulmonary edema (ARDS), angioedema, dependent edema
Tissue injury	Extravasated blood/proteins → inflammation, fibrosis	Compartment syndrome, radiation fibrosis
Infection spread	Bacteria enter via disrupted barrier	Sepsis from gut translocation, necrotizing fasciitis
Thrombosis	Subendothelial collagen exposure → platelet adhesion, coagulation cascade	DVT, arterial thrombosis, DIC

Major Pathological Triggers

• Inflammation: Sepsis, anaphylaxis, burns, pancreatitis, autoimmune (SLE, vasculitis).
• Mechanical: Trauma, hypertension (shear stress), ischemia-reperfusion.
• Toxic/Metabolic: Chemotherapy (VEGF inhibitors), contrast nephropathy, uremia.
• Iatrogenic: Extravasation of vesicants, radiation.

Prevention Strategies

1. Blood pressure control: Target <130/80 (ACC/AHA); prevents hypertensive vasculopathy.
2. Glycemic control: HbA1c <7% → ↓ advanced glycation end-products (AGEs) → preserves glycocalyx.
3. Lipid management: Statins → pleiotropic endothelial stabilization (↑ NO, ↓ inflammation).
4. Smoking cessation: Restores NO bioavailability, ↓ oxidative stress.
5. Anti-inflammatory lifestyle: Mediterranean diet, exercise, weight loss, sleep.
6. Medication safety: Anticoagulant/antiplatelet monitoring (INR, anti-Xa); avoid NSAIDs in high-risk.
7. Trauma prevention: Seatbelts, fall prevention (elderly), PPE.
8. Regular screening: ABI, carotid IMT, retinal exam, microalbuminuria (early endothelial dysfunction markers).

Acute Leakage Management

• Source control (surgery, embolization).
• Volume resuscitation (balanced crystalloids, blood products).
• Vasopressors (norepinephrine) if distributive shock.
• Specific antidotes (e.g., C1 esterase inhibitor for hereditary angioedema).